Q32 Bio Inc. is a biotechnology company focused on developing therapies to treat severe autoimmune and inflammatory diseases. The company leverages its deep understanding of immune system biology to create novel treatments that address the underlying causes of these debilitating conditions. Q32 Bio’s pipeline includes both antibody-based therapies and targeted cytokine inhibitors, designed to modulate […]
Read MoreBuy Price: $4.40 or better Sell Price: TradersPro Sell Signal Immutep Limited, a biotech company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its principal product candidate is IMP321, also known as Âeftilagimod alpha’ or Âefti’, which is a recombinant […]
Read More